Oracle Introduces AI Agents to Enhance Clinical Trial Operations for Life Sciences Organizations
Oracle has launched Oracle Life Sciences AI Agents, a new agentic experience designed to bring AI-assisted operational intelligence and coordination to clinical trials. These AI agents are engineered to integrate insights from Oracle Life Sciences applications and supported third-party data sources, enabling clinical trial teams to identify operational issues, recommend actions for review and approval, and coordinate responses across various clinical development workflows. For instance, an AI agent can monitor study performance, pinpoint likely drivers of Key Performance Indicator (KPI) variances, and suggest operational actions that align with trial protocols. Currently available to early adopters, these AI agents are focused on portfolio monitoring, trial planning, and trial conduct. Oracle plans to expand these AI-assisted capabilities into other clinical development areas, including clinical data management, post-trial analytics, trial design, and post-market workflows. The system is designed to operat...